miR-155-5p regulates mesenchymal stem cell osteogenesis and proliferation by targeting GSK3B in steroid-associated

Fei Wu1, Wei Huang2, Yue Yang1

  • 1Department of Orthopedics, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.

Cell Biology International
|September 29, 2020
PubMed

Insights

Reduced miR-155-5p in steroid-associated osteonecrosis of the femoral head (ONFH) impairs bone cell growth and differentiation. This occurs by increasing GSK3B, which inhibits Wnt signaling crucial for bone formation.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Orthopedics

Background:

  • MicroRNAs (miRNAs) are critical regulators in bone diseases.
  • Steroid-associated osteonecrosis of the femoral head (ONFH) involves impaired bone metabolism.

Purpose of the Study:

  • To investigate the role of miR-155-5p in steroid-associated ONFH.
  • To determine if reduced miR-155-5p affects osteogenic differentiation and proliferation via GSK3B.

Main Methods:

  • Mesenchymal stem cells (MSCs) isolated from ONFH and control patients.
  • Analysis of miR-155-5p expression, cell proliferation, and osteogenic differentiation.
  • Luciferase reporter assays to confirm GSK3B interaction.

Main Results:

  • miR-155-5p levels were significantly lower in ONFH samples.
  • miR-155-5p promoted MSC proliferation and osteogenic differentiation by inhibiting GSK3B.
  • Inhibition of GSK3B led to β-catenin nuclear translocation and increased osteogenesis-related gene expression.

Conclusions:

  • Reduced miR-155-5p in steroid-associated ONFH contributes to impaired osteogenesis.
  • The mechanism involves elevated GSK3B levels and subsequent Wnt signaling inhibition.
  • miR-155-5p may be a therapeutic target for steroid-associated ONFH.